CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species
Zhang, Ying1,2; Yao, Lingling3,4,5; Tang, Chunping4,5; Jiang, Jianlan1; Ye, Yang3,4,5; Liu, Jia2
刊名BIOMEDICAL CHROMATOGRAPHY
2021-08-23
页码8
关键词gut microbiota LC-MS PPD-type ginsenosides species
ISSN号0269-3879
DOI10.1002/bmc.5219
通讯作者Jiang, Jianlan(jljiang@tju.edu.cn) ; Ye, Yang(yye@simm.ac.cn) ; Liu, Jia(jia.liu@simm.ac.cn)
英文摘要Ginsenosides Rb1, Rb2, Rb3 and Rc, four major protopanaxadiol (PPD)-type ginsenosides, can be metabolized by gut microbiota. The composition of gut microbiota varies in different species. Existing publications have reported the metabolite fates of ginsenosides by gut microbiota from single species. However, their microbiota-related metabolic species differences have not been evaluated yet. In current study, in vitro anaerobic incubations of PPD-type ginsenosides with gut microbiota from humans, rabbits and rats were conducted. The metabolites of each ginsenoside were then identified by LC-MS. A total of 15 metabolites from the four ginsenosides were identified. The major metabolic pathways were stepwise removals of the C-20 and C-3 sugar moieties to obtain aglycone PPD. The results showed that the hydrolysis rate of C-20 terminal beta-D-glucopyranosyl was significantly higher than those of alpha-L-arabinopyranosyl, beta-D-xylopyranosyl and alpha-L-arabinofuranosyl in different species. The activity of beta-glucosidase, the metabolic rates of parent compounds and the formation rates of their metabolites were significantly higher in gut microbiota from rabbits than from humans and rats. Our research draws researchers' attention to the species differences of microbiota-related drug metabolism.
资助项目Science and Technology Commission of Shanghai Municipality[20430780300] ; National Natural Science Foundation of China[81803610]
WOS关键词HUMAN INTESTINAL MICROFLORA ; PANAX-QUINQUEFOLIUS ; GINSENG SAPONINS ; BIOTRANSFORMATION ; EXTRACT ; IDENTIFICATION ; PHARMACOLOGY ; BIOACTIVITY ; PROFILE ; GENE
WOS研究方向Biochemistry & Molecular Biology ; Chemistry ; Pharmacology & Pharmacy
语种英语
出版者WILEY
WOS记录号WOS:000687349100001
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/297952]  
专题中国科学院上海药物研究所
通讯作者Jiang, Jianlan; Ye, Yang; Liu, Jia
作者单位1.Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300350, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China
3.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Med, Nat Prod Chem Dept, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Ying,Yao, Lingling,Tang, Chunping,et al. Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species[J]. BIOMEDICAL CHROMATOGRAPHY,2021:8.
APA Zhang, Ying,Yao, Lingling,Tang, Chunping,Jiang, Jianlan,Ye, Yang,&Liu, Jia.(2021).Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species.BIOMEDICAL CHROMATOGRAPHY,8.
MLA Zhang, Ying,et al."Qualitatively and quantitatively investigating the metabolism of 20(S)-protopanaxadiol-type ginsenosides by gut microbiota of different species".BIOMEDICAL CHROMATOGRAPHY (2021):8.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace